You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Loperamide Hydrochloride And Simethicone patents expire, and what generic alternatives are available?

Loperamide Hydrochloride And Simethicone is a drug marketed by Perrigo, Aurobindo Pharma Ltd, Bionpharma, Granules, Guardian Drug, Hetero Labs Ltd V, Perrigo R And D, and Sun Pharm Inds Ltd. and is included in eight NDAs.

The generic ingredient in LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Loperamide Hydrochloride And Simethicone

A generic version of LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE was approved as loperamide hydrochloride; simethicone by PERRIGO R AND D on September 5th, 2018.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE?
  • What are the global sales for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE?
  • What is Average Wholesale Price for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE?
Summary for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
Drug patent expirations by year for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
Recent Clinical Trials for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
McNeil ABPhase 1
BiogenPhase 4
Rocky Mountain MS Research Group, LLCPhase 4

See all LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE clinical trials

Pharmacology for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists
Physiological EffectSkin Barrier Activity

US Patents and Regulatory Information for LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET, CHEWABLE;ORAL 076029-001 Aug 30, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo R And D LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 209837-001 Sep 5, 2018 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Granules LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 215981-001 Aug 29, 2022 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Inds Ltd LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 077500-001 Sep 6, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 211059-001 Dec 14, 2020 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bionpharma LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 213484-001 Sep 10, 2021 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd V LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 211438-001 Jun 17, 2021 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.